India — Macaroni and Noodle Products — Noodles-Pasta

Higher risk. India ranks 1st of 4 origins shipping noodles-pasta to the US on border rejections per $1 billion of US imports, at 4,280 — the highest of them.

least riskmost risk

← back to leaderboard

India received 171 FDA import refusals in Noodles-Pasta, part of Macaroni and Noodle Products between 2023-Q4 and 2026-Q3. Volume peaked at 43 in 2024-Q4, with the trend falling sharply year-on-year. The most-cited issues are filthy, nutrit lbl, and list ingre. Measured against US import value, that runs at 4,280 notifications per $1 billion of imports of this commodity from India over the last 3 years.

Of these, 150 were hazard refusals and 21 were paperwork refusals.

Exporting from India? Get an email when shipments from India are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

9 2023-Q4 2023-Q4: 9 4 2024-Q1 2024-Q1: 4 10 2024-Q2 2024-Q2: 10 16 2024-Q3 2024-Q3: 16 43 2024-Q4 2024-Q4: 43 11 2025-Q1 2025-Q1: 11 20 2025-Q2 2025-Q2: 20 20 2025-Q3 2025-Q3: 20 6 2025-Q4 2025-Q4: 6 17 2026-Q1 2026-Q1: 17 9 2026-Q2 2026-Q2: 9 6 2026-Q3 2026-Q3: 6

Recent rejections